SER-155 is under clinical development by Seres Therapeutics and currently in Phase I for Graft Versus Host Disease (GVHD). According to GlobalData, Phase I drugs for Graft Versus Host Disease (GVHD) ...
Following SER-155 administration, there was a statistically significant decrease in fecal albumin, an established biomarker of epithelial barrier integrity, and a positive impact on biomarkers of ...
SER sees its comprehensive AI capabilities and user experience as key reasons for recognition as a Leader CEO Dr. John Bates says, “We believe that Doxis is ideally suited to help companies ...
The trio he formed with Noel Paul Stookey and Mary Travers became a pop phenomenon, scoring hits like “If I Had a Hammer” and “Puff the Magic Dragon.” By Jim Farber Peter Yarrow, whose ...